Application is being reviewed under the US FDA’s Real-Time Oncology Review pilot programme Based on results of the Phase III IMpower010 study, presented at ASCO, that showed adjuvant Tecentriq improved disease-free survival by more than one-third in PD-L1-positive early-stage lung cancer, compared with … Read the full press release
Posted in Healthcare, Marketing, News, Pharma & Biotech, Switzerland
Tagged atezolizumab, Cancer Immunotherapy, chemotherapy, FDA, Levi Garraway, lung cancer, non-small cell lung cancer, NSCLC, Real-Time Oncology Review, Roche, sBLA, supplemental Biologics License Application, Tecentriq®, treatment, tumours
Brussels, 15-4-2013 — /europawire.eu/ — Androulla Vassiliou, Commissioner for Education, Culture, Multilingualism and Youth, will visit the European Organization for Nuclear Research (CERN) in Geneva, Switzerland, on 15 April to meet scientists and researchers supported with funding from the EU Marie Curie Actions. Members of the team … Read the full press release
Posted in Belgium, European Union, Government, Healthcare, Pharma & Biotech, Politics, Science, Society, Switzerland
Tagged 3D imaging, 3D medical imaging, Androulla Vassiliou, cancer treatments, CERN, digital medical imaging for radiotherapy, ENTERVISION, European Organization for Nuclear Research, Geneva, Higgs particle, Marie Curie Actions, Marie Skłodowska-Curie Actions, radiotherapy, researchers, scientists, sub-atomic particles, tumours, X-ray technology
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
